Activities of garenoxacin (BMS-284756) and other agents against anaerobic clinical isolates.
about
Genetic determinant of intrinsic quinolone resistance in Fusobacterium canifelinum.In vitro activities of DX-619 and four comparator agents against 376 anaerobic bacterial isolates.Antimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources.
P2860
Activities of garenoxacin (BMS-284756) and other agents against anaerobic clinical isolates.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Activities of garenoxacin (BMS ...... t anaerobic clinical isolates.
@en
Activities of garenoxacin
@nl
type
label
Activities of garenoxacin (BMS ...... t anaerobic clinical isolates.
@en
Activities of garenoxacin
@nl
prefLabel
Activities of garenoxacin (BMS ...... t anaerobic clinical isolates.
@en
Activities of garenoxacin
@nl
P2860
P1476
Activities of garenoxacin (BMS ...... t anaerobic clinical isolates.
@en
P2093
David W Hecht
J R Osmolski
P2860
P304
P356
10.1128/AAC.47.3.910-916.2003
P407
P577
2003-03-01T00:00:00Z